AI-generated summary
The authors report a case series of four men aged 67 to 84 with diabetic foot ulcers who used a consumer home-use photobiomodulation device as an adjunct to standard care. All wounds closed within one to three weeks with no reported adverse events, and some patients reported pain reduction. The authors note these are preliminary observations from a small case series.
- Participants
- 4
- Who or what was studied
- Four men aged 67 to 84 years with diabetic foot ulcers or diabetic leg ulcers and type 2 diabetes
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The study is a small case series of four patients without a control group, and the authors describe the findings as preliminary.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on doi.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Low-level laser therapy, Light-emitting diode, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.